Literature DB >> 10878286

Mechanisms of action of cyclosporine.

S Matsuda1, S Koyasu.   

Abstract

Cyclosporine (cyclosporin A, CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes in activated T cells. It is well established that CsA through formation of a complex with cyclophilin inhibits the phosphatase activity of calcineurin, which regulates nuclear translocation and subsequent activation of NFAT transcription factors. In addition to the calcineurin/NFAT pathway, recent studies indicate that CsA also blocks the activation of JNK and p38 signaling pathways triggered by antigen recognition, making CsA a highly specific inhibitor of T cell activation. Here we discuss the action of CsA on JNK and p38 activation pathways. We also argue the potential of CsA and its natural counterparts as pharmacological probes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878286     DOI: 10.1016/s0162-3109(00)00192-2

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  163 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Inhibitory actions of HERG currents by the immunosuppressant drug cyclosporin a.

Authors:  Seung Ho Lee; Sang June Hahn; Gyesik Min; Jimok Kim; Su-Hyun Jo; Han Choe; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

3.  Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D.

Authors:  Hong Zhu; Hee Yun Suk; Raymond Y L Yu; Deborah Brancho; Opeyemi Olabisi; Teddy T C Yang; XiaoYong Yang; Jialin Zhang; Mustapha Moussaif; Jorge L Durand; Linda A Jelicks; Ja-Young Kim; Philipp E Scherer; Philippe G Frank; Michael P Lisanti; John W Calvert; Mark R Duranski; David J Lefer; Elaine Huston; George S Baillie; Miles D Houslay; Jeffrey D Molkentin; Jianping Jin; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

4.  Do plant cyclotides have potential as immunosuppressant peptides?

Authors:  Carsten Gründemann; Johannes Koehbach; Roman Huber; Christian W Gruber
Journal:  J Nat Prod       Date:  2012-01-24       Impact factor: 4.050

5.  Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.

Authors:  C A Harrison; R Bastan; M J Peirce; M R Munday; P T Peachell
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

Review 6.  PharmGKB summary: cyclosporine and tacrolimus pathways.

Authors:  Julia M Barbarino; Christine E Staatz; Raman Venkataramanan; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089

7.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

8.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

Review 9.  Epithelial-immune cell interaction in dry eye.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva; De-Quan Li; Michael E Stern
Journal:  Cornea       Date:  2008-09       Impact factor: 2.651

10.  Modulation of NFAT-5, an outlying member of the NFAT family, in human keratinocytes and skin.

Authors:  Wael I Al-Daraji; John Afolayan; Bettina G Zelger; Adel Abdellaoui; Bernhard Zelger
Journal:  Am J Transl Res       Date:  2009-01-22       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.